Show simple item record

dc.contributor.authorPoon, Zhiyong
dc.contributor.authorLee, Jung Ah
dc.contributor.authorHuang, Shenwen
dc.contributor.authorPrevost, Richard J.
dc.contributor.authorHammond, Paula T.
dc.date.accessioned2015-10-21T15:13:02Z
dc.date.available2015-10-21T15:13:02Z
dc.date.issued2010-09
dc.date.submitted2010-07
dc.identifier.issn15499634
dc.identifier.urihttp://hdl.handle.net/1721.1/99388
dc.description.abstractA novel linear-dendritic block copolymer has been synthesized and evaluated for targeted delivery. The use of the dendron as the micellar exterior block in this architecture allows the presentation of a relatively small quantity of ligands in clusters for enhanced targeting, thus maintaining a long circulation time of these “patchy” micelles. The polypeptide linear hydrophobic block drives formation of micelles that carry core-loaded drugs, and their unique design gives them extremely high stability in vivo. We have found that these systems lead to extended time periods of increased accumulation in the tumor (up to 5 days) compared with nontargeted vehicles. We also demonstrate a fourfold increase in efficacy of paclitaxel when delivered in the targeted nanoparticle systems, while significantly decreasing in vivo toxicity of the chemotherapy treatment.en_US
dc.description.sponsorshipNational Institute for Biomedical Imaging and Bioengineering (U.S.)en_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (R01EB008082-01A2)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.nano.2010.07.008en_US
dc.rightsCreative Commons Attribution-Noncommercial-NoDerivativesen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleHighly stable, ligand-clustered “patchy” micelle nanocarriers for systemic tumor targetingen_US
dc.typeArticleen_US
dc.identifier.citationPoon, Zhiyong, Jung Ah Lee, Shenwen Huang, Richard J. Prevost, and Paula T. Hammond. “Highly Stable, Ligand-Clustered ‘patchy’ Micelle Nanocarriers for Systemic Tumor Targeting.” Nanomedicine: Nanotechnology, Biology and Medicine 7, no. 2 (April 2011): 201–209.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineeringen_US
dc.contributor.mitauthorPoon, Zhiyongen_US
dc.contributor.mitauthorLee, Jung Ahen_US
dc.contributor.mitauthorHuang, Shenwenen_US
dc.contributor.mitauthorPrevost, Richard J.en_US
dc.contributor.mitauthorHammond, Paula T.en_US
dc.relation.journalNanomedicine: Nanotechnology, Biology and Medicineen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsPoon, Zhiyong; Lee, Jung Ah; Huang, Shenwen; Prevost, Richard J.; Hammond, Paula T.en_US
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record